Your Article Summary
See Latest ArticlesNatriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension
Seminars in Arthritis and Rheumatism, 06/23/09
Dimitroulas T et al. – Study concludes that systemic sclerosis (SSc) patients, particularly those with pulmonary arterial hypertension (PAH), have a derangement of the neurohormonal system, which worsens with disease severity and disease progression. Natriuretic peptides (NP) seem to be suitable noninvasive biomarkers for SSc PAH patients in terms of screening, diagnostic evaluation, risk stratification, and response to therapy, and this merits prospective evaluation.
Methods- Review to examine the evidence for the physiologic, diagnostic, and prognostic role of NP in the context of SSc PAH
- Medline search for articles published between Jan 1999 and Dec 2008
- Keywords: natriuretic peptides, systemic sclerosis or scleroderma, and pulmonary arterial hypertension
- In pts with SSc PAH, NP levels increase in proportion to the extent of right ventricular dysfunction
- They correlate significantly with functional capacity and echocardiographic and hemodynamic parameters
- NP may also provide prognostic information beyond conventional risk markers
- However, their use has to be considered against the background of the parameters that may influence their concentration
Related Articles
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 89%
Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis
Internal Medicine Journal, 10/21/09
Relevance Score: 88%
Is pulmonary arterial hypertension really a late complication of systemic sclerosis
Chest, 10/12/09
Relevance Score: 86%
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 82%
Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells from Patients with Idiopathic Pulmonary Arterial Hypertension
Journal of Cardiovascular Pharmacology, 10/12/09
Relevance Score: 81%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
British Journal of Cancer, 12/18/09
Increase in Passive Stiffness at Reduced Airway Smooth Muscle Length: Potential Impact on Airway Responsiveness
Lung Cellular and Molecular Physiology, 12/18/09
Modulation of epithelial sodium channel activity by lipopolysaccharide in alveolar type II cells: Involvement of purinergic signaling
Lung Cellular and Molecular Physiology, 12/18/09
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study
Journal of Thrombosis and Haemostasis, 12/18/09
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients
Journal of Thrombosis and Haemostasis, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09